EWM
INBX icon

Empirical Wealth Management’s Inhibrx INBX Stock Holding History

Empirical Wealth Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Hold
22,584
– – 0.03% 257
2026
Q1 		$1.52M Sell
22,584
-299
-1% -$22.2K 0.03% 286
2025
Q4 		$1.81M Buy
22,883
+299
+1% +$20.4K 0.03% 254
2025
Q3 		$761K Hold
22,584
– – 0.02% 370
2025
Q2 		$322K Hold
22,584
– – 0.01% 518
2025
Q1 		$316K Hold
22,584
– – 0.01% 502
2024
Q4 		$348K Buy
+22,584
New +$344K 0.01% 473

Other funds holding INBX

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
PCM
Presidio Capital Management San Diego, California $400M AUM 22.73% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Empirical Wealth Management's INBX Position: Q2 2026 in Review

Empirical Wealth Management held its Inhibrx (INBX) position steady in Q2 2026 at 22,584 shares worth $2.14M. The position accounts for 0.03% of the portfolio, ranked #257.

Empirical Wealth Management first reported a position in INBX in Q4 2024 and has held it in 7 quarters since. 10 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Empirical Wealth Management held 22,584 shares of Inhibrx worth $2.14M as of Q2 2026.
  • Empirical Wealth Management left its Inhibrx share count unchanged in Q2 2026.
  • Inhibrx made up 0.03% of Empirical Wealth Management's portfolio in Q2 2026, its #257 holding.
  • Empirical Wealth Management first reported a position in Inhibrx in Q4 2024 and has held it in 7 quarters since.
  • 10 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.